Terconazole and Death - a phase IV clinical study of FDA data

Summary:

Death is reported as a side effect among people who take Terconazole (terconazole), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Prevacid, and have Parkinson's disease.

The study is created by eHealthMe based on reports of 987 people who have side effects when taking Terconazole from the FDA, and is updated regularly.

What is Terconazole?

Terconazole has active ingredients of terconazole. It is often used in vaginal yeast infection. eHealthMe is studying from 1,004 Terconazole users. Check the latest studies of Terconazole.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

987 people reported to have side effects when taking Terconazole.
Among them, 12 people (1.22%) died.

Among these 12 people:

How long have people been on Terconazole when they died? *

What is the gender of people who died when taking Terconazole? *

female: 91.67 %
male: 8.33 %

What is the age of people who died when taking Terconazole? *

What are other drugs people take besides Terconazole? *

What are other side effects people have before they died? *

Chronic Kidney Disease: 3 people, 25.00%
Abdominal Pain: 2 people, 16.67%
Urinary Tract Infection: 2 people, 16.67%
Acute Kidney Failure: 2 people, 16.67%
Drowsiness: 2 people, 16.67%
Gastritis (inflammation of stomach): 1 person, 8.33%
Confusional State: 1 person, 8.33%
Dermatitis Contact (skin reaction (dermatitis) resulting from exposure to allergens): 1 person, 8.33%
Diabetes: 1 person, 8.33%
Dizziness: 1 person, 8.33%

What are the existing conditions these people have? *

Depression: 3 people, 25.00%
Parkinson's Disease: 3 people, 25.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 16.67%
High Blood Pressure: 2 people, 16.67%
Type 2 Diabetes: 1 person, 8.33%
Multiple Myeloma (cancer of the plasma cells): 1 person, 8.33%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 8.33%
Diabetes: 1 person, 8.33%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 8.33%
Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Terconazole:

Terconazole (1,004 reports)

Expand to all the drugs that have ingredients of terconazole:

Death and drugs with ingredients of terconazole (16 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Terconazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Death:

Death (3,107 drugs)

Browse all the conditions that are associated with Death:

Death (3,686 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on terconazole (the active ingredients of Terconazole) and Terconazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.